Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 23360139)

1.

Synthesis, DNA binding, hemolysis assays and anticancer studies of copper(II), nickel(II) and iron(III) complexes of a pyrazoline-based ligand.

Saleem K, Wani WA, Haque A, Lone MN, Hsieh MF, Jairajpuri MA, Ali I.

Future Med Chem. 2013 Feb;5(2):135-46. doi: 10.4155/fmc.12.201.

PMID:
23360139
2.

Synthesis and synergistic antifungal activities of a pyrazoline based ligand and its copper(II) and nickel(II) complexes with conventional antifungals.

Ali I, Wani WA, Khan A, Haque A, Ahmad A, Saleem K, Manzoor N.

Microb Pathog. 2012 Aug;53(2):66-73. doi: 10.1016/j.micpath.2012.04.005. Epub 2012 Apr 30.

PMID:
22575887
3.
4.

Copper(I) and nickel(II) complexes with 1:1 vs. 1:2 coordination of ferrocenyl hydrazone ligands: do the geometry and composition of complexes affect DNA binding/cleavage, protein binding, antioxidant and cytotoxic activities?

Krishnamoorthy P, Sathyadevi P, Butorac RR, Cowley AH, Bhuvanesh NS, Dharmaraj N.

Dalton Trans. 2012 Apr 21;41(15):4423-36. doi: 10.1039/c2dt11938b. Epub 2012 Feb 17.

PMID:
22344370
5.

DNA condensation by copper(II) complexes and their anti-proliferative effect on cancerous and normal fibroblast cells.

Rajalakshmi S, Kiran MS, Nair BU.

Eur J Med Chem. 2014 Jun 10;80:393-406. doi: 10.1016/j.ejmech.2014.04.064. Epub 2014 Apr 24.

PMID:
24794771
6.

Cytotoxic effect, differentiation, inhibition of growth and theoretical calculations of an N,N-donor ligands and its platinum(II), palladium(II) and copper(II) complexes.

Miernicka M, Szulawska A, Czyz M, Lorenz IP, Mayer P, Karwowski B, Budzisz E.

J Inorg Biochem. 2008 Feb;102(2):157-65. Epub 2007 Aug 10.

PMID:
17868889
7.

Synthesis, X-ray structure and cytotoxic effect of nickel(II) complexes with pyrazole ligands.

Sobiesiak M, Lorenz IP, Mayer P, Woźniczka M, Kufelnicki A, Krajewska U, Rozalski M, Budzisz E.

Eur J Med Chem. 2011 Dec;46(12):5917-26. doi: 10.1016/j.ejmech.2011.10.001. Epub 2011 Oct 15.

PMID:
22047642
8.

Two new Co(II) and Ni(II) complexes with 3-(2-Pyridyl)pyrazole-based ligand: synthesis, crystal structures, and bioactivities.

Liu CS, Zhang H, Chen R, Shi XS, Bu XH, Yang M.

Chem Pharm Bull (Tokyo). 2007 Jul;55(7):996-1001.

9.

Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.

Quirante J, Ruiz D, Gonzalez A, López C, Cascante M, Cortés R, Messeguer R, Calvis C, Baldomà L, Pascual A, Guérardel Y, Pradines B, Font-Bardía M, Calvet T, Biot C.

J Inorg Biochem. 2011 Dec;105(12):1720-8. doi: 10.1016/j.jinorgbio.2011.09.021. Epub 2011 Sep 22.

PMID:
22104300
10.

Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.

Loganathan R, Ramakrishnan S, Suresh E, Riyasdeen A, Akbarsha MA, Palaniandavar M.

Inorg Chem. 2012 May 21;51(10):5512-32. doi: 10.1021/ic2017177. Epub 2012 May 4.

PMID:
22559171
11.

Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.

Ramakrishnan S, Shakthipriya D, Suresh E, Periasamy VS, Akbarsha MA, Palaniandavar M.

Inorg Chem. 2011 Jul 18;50(14):6458-71. doi: 10.1021/ic1024185. Epub 2011 Jun 14.

PMID:
21671566
12.

Induction of cell death by ternary copper(II) complexes of L-tyrosine and diimines: role of coligands on DNA binding and cleavage and anticancer activity.

Ramakrishnan S, Rajendiran V, Palaniandavar M, Periasamy VS, Srinag BS, Krishnamurthy H, Akbarsha MA.

Inorg Chem. 2009 Feb 16;48(4):1309-22. doi: 10.1021/ic801144x.

PMID:
19140687
13.

Nickel, copper, and zinc centered ruthenium-substituted porphyrins: effect of transition metals on photoinduced DNA cleavage and photoinduced melanoma cell toxicity.

Sweigert P, Xu Z, Hong Y, Swavey S.

Dalton Trans. 2012 May 7;41(17):5201-8. doi: 10.1039/c2dt12331b. Epub 2012 Mar 14.

PMID:
22414966
14.

Coordination behavior of tetraaza [N₄] ligand towards Co(II), Ni(II), Cu(II), Cu(I) and Pd(II) complexes: synthesis, spectroscopic characterization and anticancer activity.

El-Boraey HA.

Spectrochim Acta A Mol Biomol Spectrosc. 2012 Nov;97:255-62. doi: 10.1016/j.saa.2012.05.077. Epub 2012 Jun 9.

PMID:
22765944
16.

Mixed-ligand copper(II)-phenolate complexes: effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity.

Rajendiran V, Karthik R, Palaniandavar M, Stoeckli-Evans H, Periasamy VS, Akbarsha MA, Srinag BS, Krishnamurthy H.

Inorg Chem. 2007 Oct 1;46(20):8208-21. Epub 2007 Sep 5.

PMID:
17784750
17.

Crystal structures, interactions with biomacromolecules and anticancer activities of Mn(II), Ni(II), Cu(II) complexes of demethylcantharate and 2-aminopyridine.

Zhang F, Lin QY, Zheng XL, Zhang LL, Yang Q, Gu JY.

J Fluoresc. 2012 Sep;22(5):1395-406. doi: 10.1007/s10895-012-1078-5. Epub 2012 Jun 26.

PMID:
22733190
18.

Evaluation of DNA binding, DNA cleavage, protein binding and in vitro cytotoxic activities of bivalent transition metal hydrazone complexes.

Krishnamoorthy P, Sathyadevi P, Cowley AH, Butorac RR, Dharmaraj N.

Eur J Med Chem. 2011 Aug;46(8):3376-87. doi: 10.1016/j.ejmech.2011.05.001. Epub 2011 May 8.

PMID:
21600679
19.
20.

Ligational behaviour of lomefloxacin drug towards Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II), Th(IV) and UO(2)(VI) ions: synthesis, structural characterization and biological activity studies.

Abd el-Halim HF, Mohamed GG, el-Dessouky MM, Mahmoud WH.

Spectrochim Acta A Mol Biomol Spectrosc. 2011 Nov;82(1):8-19. doi: 10.1016/j.saa.2011.05.089. Epub 2011 Jun 1.

PMID:
21855402
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk